USE OF THE COMBINATION OF SEMAPHORIN-4D INHIBITORY MOLECULES AND VEGF INHIBITORY MOLECULES TO INHIBIT ANGIOGENESIS

摘要

Provided herein are methods for inhibiting tumor angiogenesis in a cancerpatient, themethod comprising administering to the subject an effective amount of a firstisolated bindingmolecule which specifically binds to semaphorin-4D (SEMA4D) and an effectiveamount of asecond isolated binding molecule which specifically binds to VEGF.